Connect with us

Spread & Containment

DAX with the help from German-French Eurobond plans soon back at 12,000 points?

DAX with the help from German-French Eurobond plans soon back at 12,000 points?

Published

on

Source: Economic Events Calendar May 25 – 29, 2020 - Admiral Markets' Forex Calendar


DAX30 CFD

The German DAX30 started the last week of trading with massive gains. While we pointed out in our last weekly market outlook that:

[…]we are still careful in terms of DAX30 CFD long engagements, even though short-term and technically we stay positive as long as the German index trades above 10,200 points.[…]

we did not expect gains of more than 5% into the start of the week.

The main driver wes the comments from Fed chairman Powell on CBS' "60 Minutes" and Merkel's and Macron's proposal of a 500 billion EU recovery fund that would offer grants to European Union regions and sectors hit hardest by the coronavirus pandemic.

In fact, this move moves the EU more in the direction of a transfer union and can be interpreted as bullish for Equities.

If the bullish momentum continues over the next few days and the DAX30 breaks above the April highs around 11,350 points, a re-test of the SMA(200) around 12,000/050 points is a realistic option.

If the DAX30 on the other hand fails to break higher, a re-test of the region around 10,200 points is likely, initiated by disappointing news around developments respectively missing progress in terms of a Coronavirus vaccine as last Tuesday with Moderna's vaccine trial not working as well as expected:

Source: Admiral Markets MT5 with MT5-SE Add-on DAX30 CFD Daily chart (between February 5, 2019 to May 22, 2020). Accessed: May 22, 2020, at 10:00pm GMT - Please note: Past performance is not a reliable indicator of future results, or future performance.

In 2015, the value of the DAX30 CFD increased by 9.56%, in 2016, it increased by 6.87%, in 2017, it increased by 12.51%, in 2018, it fell by 18.26%, in 2019, it increased by 26.44% meaning that after five years, it was up by 34.2%.

Check out Admiral Markets' most competitive conditions on the DAX30 CFD and start trading on the DAX30 CFD with a low 0.8 point spread offering during the main Xetra trading hours!


US Dollar

And again: when looking at the USD Index Future, the picture hasn't significantly changed over the last few days, but with the Euro about to gain momentum against the Greenback, the USD Index Future could see a sharp drop back below 100.00 points in the days to come.

Our USD scepticism was elevated again, by Fed chairman Powell's appearance on CBS' "60 Minutes" on May 17.

In fact, we see a confirmation in his remarks in front of the US congress on May 13, in which one could easily interpret that the Fed will do everything and flood markets with trillions of US dollars if necessary to avoid a collapse of the US economy.

On CBS he said that "In the long run and even in the medium run, you wouldn't want to bet against the American economy" while acknowledging that the unemployment rate could hit as high as 25%.

If we have to translate this, we'd say it means that a worsening situation in regards to the US economy should be expected, but that the Fed will deliver the fuel which is needed to keep "the engine" running.

An anticipation of this "liquidity boost" could rather sooner than later result in a sustainable drop in 10-year US Treasury yields below 0.60%, bringing the USD under pressure, probably especially against the Euro after Merkel's and Macron's 500 billion Euro EU recovery fund (further details in the Euro paragraph).

Still, technically the USD Index Future can be considered neutral between 94.00 and 104.00 points:

Source: Barchart - U.S Dollar Index - Weekly Nearest OHLC Chart (between July 2017 to May 2020). Accessed: May 22, 2020, at 10:00 PM GMT

Don't forget to register for the weekly "Trading Spotlight" webinar with presenters including Jens Klatt, every Monday, Wednesday and Friday at 2pm London time! It's your opportunity to follow Jens and others as they explore the weekly market outlook in detail, so don't miss out!


Euro

In our last weekly market outlook we wrote

[…]While the Euro presented itself stable (and choppy) against the US dollar over the last week of trading and the performance could be interpreted as quite strong after the German Constitutional Court ruling on the 05th of May, we stay sceptical for the Euro.[…]

and that

[…]the Euro (is) vulnerable to upcoming uncertainty and leaves the current yearly lows around 1.0630 and making even a significant drop lower on the table, is probably a little under-priced into the currency in our opinion.[…]

Well, the Euro-tide has turned over the last week of trading and we are now Euro bullish.

On Monday, Germany and France respectively Merkel and Macron proposed a 500 billion EU recovery fund that would offer grants to European Union regions and sectors hit hardest by the coronavirus pandemic.

In fact, one could see this as a first step towards a transfer union and is, in addition with the massive monetary stimulus from the ECB, bullish for the Euro.

Indeed, the EUR/USD gained bullish momentum and is currently eyeing the region around 1.1000 with a break higher levelling the path up to 1.1200 and probably even higher in the months to come.

This is probably especially true, since the US dollar should stay under pressure and while European yields should stay "bid", a sustainable drop in 10-year US Treasury yields below 0.60% would narrow the yield differential between EU and US bonds further, favouring gains in the EUR/USD:

Source: Admiral Markets MT5 with MT5-SE Add-on EUR/USD Daily chart (between March 25, 2019, to May 22, 2020). Accessed: May 22, 2020, at 10:00pm GMT - Please note: Past performance is not a reliable indicator of future results, or future performance.

In 2015, the value of the EUR/USD fell by 10.2%, in 2016, it fell by 3.2%, in 2017, it increased by 13.92%, 2018, it fell by 4.4%, 2019, it fell by 2.2%, meaning that after five years, it was down by 7.3%.


JPY

While the overall picture in the USD/JPY didn't change over the last week of trading, did the stable performance in US yields help the currency pair to make fresh monthly highs.

Still, the sustainability of this move should be questioned and we keep our overall bearish outlook on the currency pair.

That may be especially true after Fed chairman Powell's appearance on CBS' "60 Minutes". After his remarks in front of the US congress on May 13, he said that "In the long run and even in the medium run, you wouldn't want to bet against the American economy" while acknowledging that the unemployment rate could hit as high as 25%.

If we have to translate this, we'd say it means that a worsening situation in regards to the US economy should be expected, but that the Fed will deliver the fuel which is needed to keep "the engine" running.

An anticipation of this "liquidity boost" could rather sooner than later result in a sustainable drop in 10-year US Treasury yields below 0.60%, bringing the USD under pressure and thus drive the USD/JPY lower, too.

That in mind, a test of the region around 105.00 and even a push lower seems a realistic option in the coming days and weeks in the USD/JPY and as long as the currency pair does not recapture 109.00/50:

Source: Admiral Markets MT5 with MT5-SE Add-on USD/JPY Daily chart (between April 1, 2019, to May 22, 2020). Accessed: May 22, 2020, at 10:00pm GMT

In 2015, the value of the USD/JPY increased by 0.5%, in 2016, it fell by 2.8%, in 2017, it fell by 3.6%, in 2018, it fell by 2.7%, in 2019, it fell by 0.85%, meaning that after five years, it was down by 9.2%.


Gold

Gold stays on its bullish path, pushing to new yearly highs last week. While technically the bearish divergence in the RSI(14) on a daily time-frame is still on the table, our take for the yellow metal stays clearly bullish, and we expect a stint to the all-time high of around 1,920 USD.

While Gold bulls should stay cautious in regards to overly aggressive long engagements with the technical bearish divergence pointing to some diminishing bullish momentum, from a fundamental perspective the path higher seems levelled.

After Powell's remarks in front of the US congress on May 13, we see a confirmation of our take from this testimony that the Fed will do everything and flood markets with trillions of US dollar if necessary to avoid a collapse of the US economy, in his appearance on CBS' "60 Minutes" where he said "In the long run and even in the medium run, you wouldn't want to bet against the American economy" while acknowledging that the unemployment rate could hit as high as 25%.

That in mind and if we get to see a sustainable drop in 10-year US Treasury yields below 0.60% in the days to come leaves us with a bullish expectation and a target around 1,920, If technically as long as we trade above 1,660 USD:

Source: Admiral Markets MT5 with MT5-SE Add-on Gold Daily chart (between February 21, 2019, to May 22, 2020). Accessed: May 22, 2020, at 10:00pm GMT - Please note: Past performance is not a reliable indicator of future results, or future performance.

In 2015, the value of Gold fell by 10.4%, in 2016, it increased by 8.1%, in 2017, it increased by 13.1%, in 2018, it fell by 1.6%, in 2019, it increased by 18.9%, meaning that after five years, it was up by 28%.


Discover the world's #1 multi-asset platform

Admiral Markets offers professional traders the ability to trade with a custom, upgraded version of MetaTrader 5, allowing you to experience trading at a significantly higher, more rewarding level. Experience benefits such as the addition of the Market Heat Map, so you can compare various currency pairs to see which ones might be lucrative investments, access real-time trading data, and so much more. Click the banner below to start your FREE download of MT5 Supreme Edition!

Download MetaTrader 5 and begin trading today!

Disclaimer: The given data provides additional information regarding all analysis, estimates, prognosis, forecasts or other similar assessments or information (hereinafter "Analysis") published on the website of Admiral Markets. Before making any investment decisions please pay close attention to the following:

  1. This is a marketing communication. The analysis is published for informative purposes only and are in no way to be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and that it is not subject to any prohibition on dealing ahead of the dissemination of investment research.
  2. Any investment decision is made by each client alone whereas Admiral Markets shall not be responsible for any loss or damage arising from any such decision, whether or not based on the Analysis.
  3. Each of the Analysis is prepared by an independent analyst (Jens Klatt, Professional Trader and Analyst, hereinafter "Author") based on the Author's personal estimations.
  4. To ensure that the interests of the clients would be protected and objectivity of the Analysis would not be damaged Admiral Markets has established relevant internal procedures for prevention and management of conflicts of interest.
  5. Whilst every reasonable effort is taken to ensure that all sources of the Analysis are reliable and that all information is presented, as much as possible, in an understandable, timely, precise and complete manner, Admiral Markets does not guarantee the accuracy or completeness of any information contained within the Analysis. The presented figures refer that refer to any past performance is not a reliable indicator of future results.
  6. The contents of the Analysis should not be construed as an express or implied promise, guarantee or implication by Admiral Markets that the client shall profit from the strategies therein or that losses in connection therewith may or shall be limited.
  7. Any kind of previous or modeled performance of financial instruments indicated within the Publication should not be construed as an express or implied promise, guarantee or implication by Admiral Markets for any future performance. The value of the financial instrument may both increase and decrease and the preservation of the asset value is not guaranteed.
  8. The projections included in the Analysis may be subject to additional fees, taxes or other charges, depending on the subject of the Publication. The price list applicable to the services provided by Admiral Markets is publicly available from the website of Admiral Markets.
  9. Leveraged products (including contracts for difference) are speculative in nature and may result in losses or profit. Before you start trading, you should make sure that you understand all the risks.

Read More

Continue Reading

International

Repeated COVID-19 Vaccination Weakens Immune System: Study

Repeated COVID-19 Vaccination Weakens Immune System: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Repeated COVID-19…

Published

on

Repeated COVID-19 Vaccination Weakens Immune System: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Repeated COVID-19 vaccination weakens the immune system, potentially making people susceptible to life-threatening conditions such as cancer, according to a new study.

A man is given a COVID-19 vaccine in Chelsea, Mass., on Feb. 16, 2021. (Joseph Prezioso/AFP via Getty Images)

Multiple doses of the Pfizer or Moderna COVID-19 vaccines lead to higher levels of antibodies called IgG4, which can provide a protective effect. But a growing body of evidence indicates that the “abnormally high levels” of the immunoglobulin subclass actually make the immune system more susceptible to the COVID-19 spike protein in the vaccines, researchers said in the paper.

They pointed to experiments performed on mice that found multiple boosters on top of the initial COVID-19 vaccination “significantly decreased” protection against both the Delta and Omicron virus variants and testing that found a spike in IgG4 levels after repeat Pfizer vaccination, suggesting immune exhaustion.

Studies have detected higher levels of IgG4 in people who died with COVID-19 when compared to those who recovered and linked the levels with another known determinant of COVID-19-related mortality, the researchers also noted.

A review of the literature also showed that vaccines against HIV, malaria, and pertussis also induce the production of IgG4.

“In sum, COVID-19 epidemiological studies cited in our work plus the failure of HIV, Malaria, and Pertussis vaccines constitute irrefutable evidence demonstrating that an increase in IgG4 levels impairs immune responses,” Alberto Rubio Casillas, a researcher with the biology laboratory at the University of Guadalajara in Mexico and one of the authors of the new paper, told The Epoch Times via email.

The paper was published by the journal Vaccines in May.

Pfizer and Moderna officials didn’t respond to requests for comment.

Both companies utilize messenger RNA (mRNA) technology in their vaccines.

Dr. Robert Malone, who helped invent the technology, said the paper illustrates why he’s been warning about the negative effects of repeated vaccination.

“I warned that more jabs can result in what’s called high zone tolerance, of which the switch to IgG4 is one of the mechanisms. And now we have data that clearly demonstrate that’s occurring in the case of this as well as some other vaccines,” Malone, who wasn’t involved with the study, told The Epoch Times.

So it’s basically validating that this rush to administer and re-administer without having solid data to back those decisions was highly counterproductive and appears to have resulted in a cohort of people that are actually more susceptible to the disease.”

Possible Problems

The weakened immune systems brought about by repeated vaccination could lead to serious problems, including cancer, the researchers said.

Read more here...

Tyler Durden Sat, 06/03/2023 - 22:30

Read More

Continue Reading

Spread & Containment

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Authored by Jack Phillips via The Epoch Times (emphasis ours),

Twitter…

Published

on

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Authored by Jack Phillips via The Epoch Times (emphasis ours),

Twitter owner Elon Musk invited Democrat presidential candidate Robert F. Kennedy Jr. for a discussion on his Twitter Spaces after Kennedy said his campaign was suspended by Meta-owned Instagram.

Interesting… when we use our TeamKennedy email address to set up @instagram accounts we get an automatic 180-day ban. Can anyone guess why that’s happening?” he wrote on Twitter.

An accompanying image shows that Instagram said it “suspended” his “Team Kennedy” account and that there “are 180 days remaining to disagree” with the company’s decision.

Robert F. Kennedy, Jr. attends Keep it Clean to benefit Waterkeeper Alliance in Los Angeles, Calif., on March 1, 2018. (John Sciulli/Getty Images for Waterkeeper Alliance)

In response to his post, Musk wrote: “Would you like to do a Spaces discussion with me next week?” Kennedy agreed, saying he would do it Monday at 2 p.m. ET.

Hours later, Kennedy wrote that Instagram “still hasn’t reinstated my account, which was banned years ago with more than 900k followers.” He argued that “to silence a major political candidate is profoundly undemocratic.”

“Social media is the modern equivalent of the town square,” the candidate, who is the nephew of former President John F. Kennedy, wrote. “How can democracy function if only some candidates have access to it?”

The Epoch Times approached Instagram for comment.

It’s not the first time that either Facebook or Instagram has taken action against Kennedy. In 2021, Instagram banned him from posting claims about vaccine safety and COVID-19.

After he was banned by the platform, Kennedy said that his Instagram posts raised legitimate concerns about vaccines and were backed by research. His account was banned just days after Facebook and Instagram announced they would block the spread of what they described as misinformation about vaccines, including research saying the shots cause autism, are dangerous, or are ineffective.

“This kind of censorship is counterproductive if our objective is a safe and effective vaccine supply,” he said at the time.

Read more here...

Tyler Durden Sat, 06/03/2023 - 20:30

Read More

Continue Reading

International

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Authored by Jessie Zhang via Thje Epoch…

Published

on

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Authored by Jessie Zhang via Thje Epoch Times (emphasis ours),

An Australian and Swedish investigation has found that among the hundreds of COVID-19 research papers that have been withdrawn, a retracted study linking the drug hydroxychloroquine to increased mortality was the most cited paper.

Hydroxychloroquine sulphate tablets. (Memories Over Mocha/Shutterstock)

With 1,360 citations at the time of data extraction, researchers in the field were still referring to the paper “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis” long after it was retracted.

Authors of the analysis involving the University of Wollongong, Linköping University, and Western Sydney Local Health District wrote (pdf) that “most researchers who cite retracted research do not identify that the paper is retracted, even when submitting long after the paper has been withdrawn.”

“This has serious implications for the reliability of published research and the academic literature, which need to be addressed,” they said.

Retraction is the final safeguard against academic error and misconduct, and thus a cornerstone of the entire process of knowledge generation.”

Scientists Question Findings

Over 100 medical professionals wrote an open letter, raising ten major issues with the paper.

These included the fact that there was “no ethics review” and “unusually small reported variances in baseline variables, interventions and outcomes,” as well as “no mention of the countries or hospitals that contributed to the data source and no acknowledgments to their contributions.”

A bottle of Hydroxychloroquine at the Medicine Shoppe in Wilkes-Barre, Pa on March 31, 2020. Some politicians and doctors were sparring over whether to use hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it yet. (Mark Moran/The Citizens’ Voice via AP)

Other concerns were that the average daily doses of hydroxychloroquine were higher than the FDA-recommended amounts, which would present skewed results.

They also found that the data that was reportedly from Australian patients did not seem to match data from the Australian government.

Eventually, the study led the World Health Organization to temporarily suspend the trial of hydroxychloroquine on COVID-19 patients and to the UK regulatory body, MHRA, requesting the temporary pause of recruitment into all hydroxychloroquine trials in the UK.

France also changed its national recommendation of the drug in COVID-19 treatments and halted all trials.

Currently, a total of 337 research papers on COVID-19 have been retracted, according to Retraction Watch.

Further retractions are expected as the investigation of proceeds.

Tyler Durden Sat, 06/03/2023 - 17:30

Read More

Continue Reading

Trending